MetaADEDB 2.0 @ LMMD
Lopinavir
(KJHKTHWMRKYKJE-SUGCFTRWSA-N)
Structure
SMILES
O=C(N[C@H]([C@H](C[C@H](Cc1ccccc1)NC(=O)[C@@H](N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C
Type(s)
Approved
ATC code(s)
J05AR10
Molecular Formula:
C37H48N4O5
Molecular Weight:
628.801
Log P:
5.3766
Hydrogen Bond Acceptor:
9
Hydrogen Bond Donor:
4
TPSA:
120
CAS Number(s):
192725-17-0
Synonym(s)
1.
Lopinavir
2.
A-157378.0
3.
ABT 378
4.
ABT-378
5.
N-(4-(((2,6-dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pydrimidineacetamide
6.
A 157378.0
7.
A157378.0
8.
ABT378
External Link(s)
MeSHD061466
PubChem Compound92727
BindingDB50180655
578
ChEBI31781
CHEMBLCHEMBL729
DrugBankDB01601
DrugCentral1601
KEGGcpd:C12871
dr:D01425
Therapeutic Target DatabaseD0U5GB
ZINC3951740
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug exposure during pregnancyFAERS: 61US FAERS
2NauseaFAERS: 35
Canada Vigilance: 1
Canada Vigilance
US FAERS
3Unevaluable eventFAERS: 34US FAERS
4VomitingFAERS: 29
Canada Vigilance: 2
Canada Vigilance
US FAERS
5Drug dose omissionFAERS: 26US FAERS
6PneumoniaFAERS: 20
Canada Vigilance: 3
Canada Vigilance
US FAERS
7Weight decreasedFAERS: 18US FAERS
8MalaiseFAERS: 14US FAERS
9Drug resistanceFAERS: 12
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
10AstheniaFAERS: 11US FAERS
11HeadacheFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
12Medication ErrorFAERS: 11US FAERS
13Blood cholesterol increasedFAERS: 10US FAERS
14FatigueFAERS: 10
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
15Incorrect dose administeredFAERS: 10US FAERS
16PolydactylyFAERS: 10US FAERS
17Blood triglycerides increasedFAERS: 9OFFSIDES
US FAERS
18CachexiaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
19Drug dispensing errorFAERS: 8US FAERS
20General physical health deteriorationFAERS: 8OFFSIDES
US FAERS
21LymphomaFAERS: 8US FAERS
22Septic ShockFAERS: 8US FAERS
23Trisomy 21FAERS: 8OFFSIDES
US FAERS
24Abdominal PainFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
25AnxietyFAERS: 7US FAERS
26Cerebrovascular accidentFAERS: 7US FAERS
27Completed SuicideFAERS: 7US FAERS
28EpistaxisFAERS: 7US FAERS
29LymphadenopathyFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
30DizzinessFAERS: 6US FAERS
31Drug administration errorFAERS: 6US FAERS
32Drug ineffectiveFAERS: 6US FAERS
33Hepatitis CFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
34Myocardial InfarctionFAERS: 6US FAERS
35NasopharyngitisFAERS: 6US FAERS
36Neonatal disorderFAERS: 6US FAERS
37OverdoseFAERS: 6US FAERS
38PancreatitisFAERS: 6US FAERS
39Acquired Immunodeficiency SyndromeFAERS: 5US FAERS
40Back PainFAERS: 5US FAERS
41Cerebellar HypoplasiaFAERS: 5US FAERS
42HepatitisFAERS: 5US FAERS
43Hypoplastic Left Heart SyndromeFAERS: 5US FAERS
44Inappropriate schedule of drug administrationFAERS: 5US FAERS
45Maternal exposure during pregnancyFAERS: 5US FAERS
46Medication residueFAERS: 5US FAERS
47Respiratory FailureFAERS: 5US FAERS
48SepsisFAERS: 5US FAERS
49Suicide attemptFAERS: 5US FAERS
50Testicular massFAERS: 5US FAERS
51ToxoplasmosisFAERS: 5US FAERS
52UveitisFAERS: 5US FAERS
53AbscessFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
54Antibiotic ProphylaxisFAERS: 4US FAERS
55ArthralgiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
56Congenital cystic lungFAERS: 4US FAERS
57DehydrationFAERS: 4US FAERS
58Diabetes MellitusFAERS: 4US FAERS
59Feeling abnormalFAERS: 4US FAERS
60GastroduodenitisFAERS: 4US FAERS
61InflammationFAERS: 4US FAERS
62Metastatic bronchial carcinomaFAERS: 4US FAERS
63Pulmonary EmbolismFAERS: 4US FAERS
64TuberculosisFAERS: 4US FAERS
65nervous system disorderFAERS: 4US FAERS
66Accidental overdoseFAERS: 3US FAERS
67Alanine Aminotransferase IncreasedFAERS: 3US FAERS
68Anal FistulaFAERS: 3US FAERS
69AnorexiaFAERS: 3US FAERS
70Atrial FibrillationFAERS: 3US FAERS
71Atrioventricular BlockFAERS: 3US FAERS
72Breech PresentationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
73Cerebral ventricle dilatationFAERS: 3OFFSIDES
US FAERS
74Chest PainFAERS: 3US FAERS
75ChillsFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
76Congenital hydronephrosisFAERS: 3US FAERS
77Congenital inguinal herniaFAERS: 3US FAERS
78Cytolytic hepatitisFAERS: 3US FAERS
79Cytomegalovirus chorioretinitisFAERS: 3US FAERS
80Diabetes mellitus inadequate controlFAERS: 3US FAERS
81DysplasiaFAERS: 3US FAERS
82Electrocardiogram abnormalFAERS: 3US FAERS
83Guillain-Barre SyndromeFAERS: 3US FAERS
84HemiparesisFAERS: 3OFFSIDES
US FAERS
85HemiplegiaFAERS: 3US FAERS
86HydrocephalusFAERS: 3US FAERS
87HypotensionFAERS: 3US FAERS
88InfluenzaFAERS: 3US FAERS
89Lipodystrophy acquiredFAERS: 3OFFSIDES
US FAERS
90LipomaFAERS: 3US FAERS
91Memory impairmentFAERS: 3US FAERS
92NephrolithiasisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
93NocturiaFAERS: 3US FAERS
94PainFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
95ParanoiaFAERS: 3US FAERS
96Pneumocystis jiroveci pneumoniaFAERS: 3OFFSIDES
US FAERS
97PneumothoraxFAERS: 3OFFSIDES
US FAERS
98PolyhydramniosFAERS: 3US FAERS
99PruritusFAERS: 3US FAERS
100RestlessnessFAERS: 3US FAERS
101Skin lesionFAERS: 3US FAERS
102SomnolenceFAERS: 3US FAERS
103StillbirthFAERS: 3US FAERS
104ThrombocytopeniaFAERS: 3US FAERS
105ThrombosisFAERS: 3US FAERS
106Viral load increasedFAERS: 3US FAERS
107Abdominal discomfortFAERS: 2US FAERS
108Accidental exposureFAERS: 2US FAERS
109Actinic keratosisFAERS: 2US FAERS
110Acute myocardial infarctionFAERS: 2OFFSIDES
US FAERS
111AlopeciaFAERS: 2US FAERS
112Altered state of consciousnessFAERS: 2US FAERS
113AphoniaFAERS: 2US FAERS
114AppendicitisFAERS: 2US FAERS
115AscitesFAERS: 2US FAERS
116Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
117AtaxiaFAERS: 2US FAERS
118BicytopeniaFAERS: 2US FAERS
119BlindnessFAERS: 2US FAERS
120Blood potassium increasedFAERS: 2US FAERS
121BradycardiaFAERS: 2US FAERS
122Brain DeathFAERS: 2US FAERS
123Burning sensationFAERS: 2US FAERS
124CD4 lymphocytes abnormalFAERS: 2US FAERS
125Caudal Regression SyndromeFAERS: 2US FAERS
126CellulitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
127Cerebral atrophyFAERS: 2US FAERS
128ChokingFAERS: 2US FAERS
129ConstipationFAERS: 2US FAERS
130DeafnessFAERS: 2US FAERS
131Dental discomfortFAERS: 2US FAERS
132DiplopiaFAERS: 2OFFSIDES
US FAERS
133Disseminated Intravascular CoagulationFAERS: 2US FAERS
134Double ureterFAERS: 2US FAERS
135Drug level increasedFAERS: 2US FAERS
136Drug prescribing errorFAERS: 2US FAERS
137DysmorphismFAERS: 2US FAERS
138EmpyemaFAERS: 2US FAERS
139EncephalitisFAERS: 2US FAERS
140EpididymitisFAERS: 2US FAERS
141Escherichia urinary tract infectionFAERS: 2US FAERS
142Failure to ThriveFAERS: 2US FAERS
143FlatulenceFAERS: 2US FAERS
144FlushingFAERS: 2US FAERS
145GastroenteritisFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
146Gastrointestinal infectionFAERS: 2US FAERS
147Gastrointestinal inflammationFAERS: 2US FAERS
148Genital HerpesFAERS: 2US FAERS
149Gestational DiabetesFAERS: 2US FAERS
150HIV Wasting SyndromeFAERS: 2US FAERS
151HepatotoxicityFAERS: 2US FAERS
152Hip DysplasiaFAERS: 2US FAERS
153HistoplasmosisFAERS: 2OFFSIDES
US FAERS
154HydronephrosisFAERS: 2US FAERS
155HypersensitivityFAERS: 2US FAERS
156HypophagiaFAERS: 2US FAERS
157Immature respiratory systemFAERS: 2US FAERS
158Immune reconstitution syndromeFAERS: 2OFFSIDES
US FAERS
159InfectionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
160Intercepted drug dispensing errorFAERS: 2US FAERS
161LacerationFAERS: 2US FAERS
162Low set earsFAERS: 2US FAERS
163MYELODYSPLASTIC SYNDROMEFAERS: 2US FAERS
164MetrorrhagiaFAERS: 2US FAERS
165Multifocal motor neuropathyFAERS: 2US FAERS
166Multiple MyelomaFAERS: 2US FAERS
167Muscle RigidityFAERS: 2US FAERS
168Musculoskeletal PainFAERS: 2US FAERS
169MyocarditisFAERS: 2US FAERS
170Night sweatsFAERS: 2US FAERS
171Optic NeuritisFAERS: 2US FAERS
172Oral candidiasisFAERS: 2US FAERS
173Otitis MediaFAERS: 2US FAERS
174PalpitationsFAERS: 2US FAERS
175PancytopeniaFAERS: 2US FAERS
176Patent ductus arteriosusFAERS: 2US FAERS
177PetechiaeFAERS: 2US FAERS
178Pharmaceutical product complaintFAERS: 2US FAERS
179PhotophobiaFAERS: 2US FAERS
180Placental InsufficiencyFAERS: 2US FAERS
181ProteinuriaFAERS: 2US FAERS
182Psoas AbscessFAERS: 2US FAERS
183Purulent dischargeFAERS: 2US FAERS
184PyelectasiaFAERS: 2US FAERS
185RhabdomyolysisFAERS: 2OFFSIDES
US FAERS
186SinusitisFAERS: 2OFFSIDES
US FAERS
187StrabismusFAERS: 2US FAERS
188Sudden deathFAERS: 2US FAERS
189SyncopeFAERS: 2US FAERS
190SynovitisFAERS: 2US FAERS
191Systemic Inflammatory Response SyndromeFAERS: 2US FAERS
192TachycardiaFAERS: 2US FAERS
193Thermal burnFAERS: 2US FAERS
194ThrombophlebitisFAERS: 2US FAERS
195Toxic Epidermal NecrolysisFAERS: 2US FAERS
196Toxicity to various agentsFAERS: 2US FAERS
197Umbilical herniaFAERS: 2US FAERS
198UnderweightFAERS: 2US FAERS
199Wrong technique in drug usage processFAERS: 2US FAERS
200jaundiceFAERS: 2US FAERS
201Abdominal InfectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
202AcidosisFAERS: 1OFFSIDES
US FAERS
203Activities of daily living impairedFAERS: 1US FAERS
204Acute psychosisFAERS: 1US FAERS
205AdenocarcinomaFAERS: 1US FAERS
206Adverse eventFAERS: 1US FAERS
207AgitationFAERS: 1US FAERS
208Alcohol withdrawal syndromeFAERS: 1US FAERS
209AnencephalyFAERS: 1US FAERS
210ArthritisFAERS: 1US FAERS
211ArthropathyFAERS: 1US FAERS
212Ascites infectionFAERS: 1US FAERS
213Atrioventricular Septal DefectFAERS: 1OFFSIDES
US FAERS
214Autoimmune thyroiditisFAERS: 1US FAERS
215Autosomal chromosome anomalyFAERS: 1US FAERS
216Bipolar DisorderFAERS: 116368918CTD
US FAERS
217Blood creatine phosphokinase increasedFAERS: 1US FAERS
218Blood creatinine increasedFAERS: 1US FAERS
219Blood glucose increasedFAERS: 1US FAERS
220Blood lactate dehydrogenase increasedFAERS: 1US FAERS
221Blood sodium decreasedFAERS: 1US FAERS
222Body fat disorderFAERS: 1US FAERS
223Bone painFAERS: 1OFFSIDES
US FAERS
224Bowel movement irregularityFAERS: 1US FAERS
225BronchitisFAERS: 1US FAERS
226CD4 Lymphocytes DecreasedFAERS: 1US FAERS
227Cardiac ArrestFAERS: 1US FAERS
228Cardiac ventricular disorderFAERS: 1US FAERS
229CatarrhFAERS: 1US FAERS
230Cerebral InfarctionFAERS: 1US FAERS
231Cerebral dysgenesisFAERS: 1US FAERS
232Cervical dysplasiaFAERS: 1US FAERS
233Cervix carcinomaFAERS: 1US FAERS
234CholelithiasisFAERS: 1US FAERS
235Clostridium colitisFAERS: 1US FAERS
236Congenital HydrocephalusFAERS: 1US FAERS
237Congenital tricuspid valve incompetenceFAERS: 1US FAERS
238Congenital urinary tract obstructionFAERS: 1US FAERS
239ConjunctivitisFAERS: 1US FAERS
240Coronary Artery DiseaseFAERS: 1US FAERS
241Creatinine renal clearance decreasedFAERS: 1US FAERS
242Cytomegalovirus testFAERS: 1US FAERS
243Depressed Level of ConsciousnessFAERS: 1US FAERS
244Device breakageFAERS: 1US FAERS
245Diverticular perforationFAERS: 1US FAERS
246Drug DependenceFAERS: 1US FAERS
247Drug screen positiveFAERS: 1US FAERS
248DysgeusiaFAERS: 1US FAERS
249DyspepsiaFAERS: 1US FAERS
250DystoniaFAERS: 1US FAERS
251Ear congestionFAERS: 1US FAERS
252Emotional distressFAERS: 1US FAERS
253Endometrial HyperplasiaFAERS: 1US FAERS
254Erectile dysfunctionFAERS: 1US FAERS
255ErythemaFAERS: 1US FAERS
256ExophthalmosFAERS: 1US FAERS
257Expired product administeredFAERS: 1US FAERS
258Febrile NeutropeniaFAERS: 1OFFSIDES
US FAERS
259Full blood count decreasedFAERS: 1US FAERS
260Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
261Gastric DilatationFAERS: 1US FAERS
262Gastric infectionFAERS: 1US FAERS
263Germ Cell CancerFAERS: 1US FAERS
264Gluten sensitivityFAERS: 1US FAERS
265GranulomaFAERS: 1US FAERS
266HELLP SyndromeFAERS: 1US FAERS
267Hepatic EncephalopathyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
268Hepatitis B positiveFAERS: 1OFFSIDES
US FAERS
269Hepatitis BFAERS: 1US FAERS
270HepatosplenomegalyFAERS: 1OFFSIDES
US FAERS
271HerniaFAERS: 1US FAERS
272HypoxiaFAERS: 1US FAERS
273Impaired gastric emptyingFAERS: 1US FAERS
274IncontinenceFAERS: 1OFFSIDES
US FAERS
275Intentional product misuseFAERS: 1US FAERS
276Intracranial AneurysmFAERS: 1US FAERS
277IridocyclitisFAERS: 1US FAERS
278KetoacidosisFAERS: 1US FAERS
279Laryngeal discomfortFAERS: 1US FAERS
280LeukocytosisFAERS: 1US FAERS
281LeukoencephalopathyFAERS: 1OFFSIDES
US FAERS
282Lipids abnormalFAERS: 1OFFSIDES
US FAERS
283LipohypertrophyFAERS: 1US FAERS
284Lobar PneumoniaFAERS: 1US FAERS
285Low birth weight babyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
286Low density lipoprotein increasedFAERS: 1US FAERS
287Lower respiratory tract infectionFAERS: 1US FAERS
288Lymph Node TuberculosisFAERS: 1US FAERS
289Lymphogranuloma VenereumFAERS: 1US FAERS
290Malignant neoplasm progressionFAERS: 1US FAERS
291Medication residue presentFAERS: 1US FAERS
292MeningomyeloceleFAERS: 1US FAERS
293Mental status changesFAERS: 1US FAERS
294MetaplasiaFAERS: 1US FAERS
295MetastasisFAERS: 1US FAERS
296Metastatic NeoplasmFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
297Mucosal erosionFAERS: 1US FAERS
298Multi-organ disorderFAERS: 1US FAERS
299Muscle FatigueFAERS: 1US FAERS
300Muscle abscessFAERS: 1US FAERS
301MyalgiaFAERS: 1US FAERS
302MyoclonusFAERS: 1US FAERS
303NephritisFAERS: 1US FAERS
304Nipple painFAERS: 1US FAERS
305Obesity surgeryFAERS: 1US FAERS
306Optic Nerve HypoplasiaFAERS: 1US FAERS
307Oropharyngeal painFAERS: 1US FAERS
308OsteoporosisFAERS: 1OFFSIDES
US FAERS
309PeritonitisFAERS: 1US FAERS
310PneumonitisFAERS: 1US FAERS
311PolyneuropathyFAERS: 1US FAERS
312Portal HypertensionFAERS: 1OFFSIDES
US FAERS
313Post procedural infectionFAERS: 1US FAERS
314Product physical consistency issueFAERS: 1US FAERS
315Product quality issueFAERS: 1US FAERS
316Product residue presentFAERS: 1US FAERS
317Product taste abnormalFAERS: 1US FAERS
318Productive CoughFAERS: 1US FAERS
319Prothrombin time abnormalFAERS: 1US FAERS
320Psychiatric symptomFAERS: 1US FAERS
321Pulmonary HypertensionFAERS: 1OFFSIDES
US FAERS
322QuadriparesisFAERS: 1US FAERS
323Respiratory arrestFAERS: 1US FAERS
324Respiratory distressFAERS: 1US FAERS
325Retinal pigment epitheliopathyFAERS: 1US FAERS
326SarcoidosisFAERS: 1US FAERS
327Sexual DysfunctionFAERS: 1US FAERS
328ShockFAERS: 1US FAERS
329Sick Sinus SyndromeFAERS: 1US FAERS
330Skin IndurationFAERS: 1US FAERS
331Skin PapillomaFAERS: 1US FAERS
332Skin reactionFAERS: 1US FAERS
333SluggishnessFAERS: 1US FAERS
334Spina Bifida OccultaFAERS: 1US FAERS
335Spina BifidaFAERS: 1US FAERS
336Spinal column stenosisFAERS: 1US FAERS
337SplenomegalyFAERS: 1US FAERS
338Stress at workFAERS: 1US FAERS
339SubileusFAERS: 1US FAERS
340SwellingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
341Tablet issueFAERS: 1US FAERS
342TachyarrhythmiaFAERS: 1US FAERS
343Terminal stateFAERS: 1US FAERS
344Therapeutic response unexpectedFAERS: 1US FAERS
345Therapy cessationFAERS: 1US FAERS
346Throat cancerFAERS: 1US FAERS
347ThrombectomyFAERS: 1US FAERS
348Thrombocytopenic purpuraFAERS: 1US FAERS
349Tooth ExtractionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
350Tooth LossFAERS: 1US FAERS
351Transaminases abnormalFAERS: 1US FAERS
352Transaminases increasedFAERS: 1OFFSIDES
US FAERS
353TremorFAERS: 1US FAERS
354Urinary tract infectionFAERS: 1US FAERS
355UrticariaFAERS: 1US FAERS
356Visual disturbanceFAERS: 1US FAERS
357Wrong drug administeredFAERS: 1US FAERS
358Acquired Protein S DeficiencyOFFSIDES
359Acute respiratory failureOFFSIDES
360AgraphiaOFFSIDES
361Aortic embolusOFFSIDES
362BlepharoptosisOFFSIDES
363Blood HIV RNAOFFSIDES
364Blood immunoglobulin A increasedOFFSIDES
365Blood immunoglobulin G increasedOFFSIDES
366Blood immunoglobulin MOFFSIDES
367Blood phosphorus decreasedOFFSIDES
368Bone infarctionOFFSIDES
369Bone marrow toxicityOFFSIDES
370Brain stem syndromeOFFSIDES
371BruxismOFFSIDES
372CD4 lymphocytes increasedOFFSIDES
373CatatoniaOFFSIDES
374Central nervous system lesionOFFSIDES
375Chemical and Drug Induced Liver Injury23956101
24014644
CTD
376Concomitant disease aggravatedCanada Vigilance: 1Canada Vigilance
377Congenital hepatobiliary anomalyOFFSIDES
378Congenital nystagmusOFFSIDES
379Consciousness fluctuatingOFFSIDES
380DemyelinationOFFSIDES
381Depressed moodOFFSIDES
382DrowsinessOFFSIDES
383Electrocardiogram QRS complexOFFSIDES
384Electromechanical dissociationOFFSIDES
385Euphoric moodOFFSIDES
386Fanconi Syndrome14689363CTD
OFFSIDES
387Fanconi like syndrome16773419CTD
388Fatty LiverOFFSIDES
389Gaze palsyOFFSIDES
390Genotype drug resistance test positiveOFFSIDES
391HIV Infections17378895
17461719
19908326
CTD
392HIV-Associated Lipodystrophy Syndrome18230615CTD
393Hepatic displacementOFFSIDES
394HyperreflexiaOFFSIDES
395HypervigilanceOFFSIDES
396HypokinesiaOFFSIDES
397HyporeflexiaOFFSIDES
398Infusion site mobility decreasedOFFSIDES
399Kidney FailureOFFSIDES
400Meconium Aspiration SyndromeCanada Vigilance: 1Canada Vigilance
401MicrocephalyOFFSIDES
402Mitochondrial toxicityOFFSIDES
403MonoparesisOFFSIDES
404Motor retardationOFFSIDES
405Myasthenia GravisOFFSIDES
406Mycobacterium Infections21442799CTD
407Necrotising granulomatous lymphadenitisOFFSIDES
408Neutropenia17378895CTD
409Nodular regenerative hyperplasiaOFFSIDES
410OphthalmoplegiaOFFSIDES
411Parkinsonian Disorders19908326CTD
412Pathological fractureCanada Vigilance: 1Canada Vigilance
413PolyuriaOFFSIDES
414Portal Vein ThrombosisOFFSIDES
415Portal hypertensive gastropathyOFFSIDES
416PsoriasisOFFSIDES
417Renal Insufficiency16773419CTD
418Renal tubular necrosisOFFSIDES
419RetinitisOFFSIDES
420SalmonellaOFFSIDES
421Skin lacerationCanada Vigilance: 1Canada Vigilance
422Status Epilepticus20851280CTD
423Therapeutic product effect decreasedCanada Vigilance: 1Canada Vigilance
424Thoracic vertebral fractureOFFSIDES
425Unresponsive to stimuliCanada Vigilance: 1Canada Vigilance
426VIIth nerve paralysisOFFSIDES
427treatment failureOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.